EI
MCRB icon

Ellevest Inc’s Seres Therapeutics MCRB Stock Holding History

Ellevest Inc’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Hold
0
– – – 1354
2021
Q1 		– Sell
-2
Closed -$921 – 1314
2020
Q4 		$1K Buy
+2
New +$1.17K ﹤0.01% 1081
2020
Q3 		– Hold
0
– – – 1239
2020
Q2 		– Hold
0
– – – 1248
2020
Q1 		– Hold
0
– – – 1215

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Ellevest Inc's MCRB Position: Q2 2021 in Review

Ellevest Inc held its Seres Therapeutics (MCRB) position steady in Q2 2021 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1354.

Ellevest Inc first reported a position in MCRB in Q4 2020 and has held it in 1 quarter since. The position peaked at $1K in Q4 2020. 146 funds tracked by Wall St. Rank hold MCRB as of Q2 2021.

  • Ellevest Inc held 0 shares of Seres Therapeutics worth $0 as of Q2 2021.
  • Ellevest Inc left its Seres Therapeutics share count unchanged in Q2 2021.
  • Seres Therapeutics made up ﹤0.01% of Ellevest Inc's portfolio in Q2 2021, its #1354 holding.
  • Ellevest Inc first reported a position in Seres Therapeutics in Q4 2020 and has held it in 1 quarter since.
  • Ellevest Inc's Seres Therapeutics position peaked at $1K in Q4 2020.
  • 146 funds tracked by Wall St. Rank held Seres Therapeutics as of Q2 2021.

Based on Ellevest Inc's 13F filing for Q2 2021, filed 13 Jul 2021.